SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-10-017686
Filing Date
2010-03-31
Accepted
2010-03-31 15:43:02
Documents
3
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a09-35926_310ka.htm 10-K/A 655961
2 EX-31.1 a09-35926_3ex31d1.htm EX-31.1 5958
3 EX-31.2 a09-35926_3ex31d2.htm EX-31.2 6415
  Complete submission text file 0001104659-10-017686.txt   669930
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-15006 | Film No.: 10718888
SIC: 2835 In Vitro & In Vivo Diagnostic Substances